Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (70,228) $ (54,342)
Reconciling items:    
Depreciation 28,936 28,947
Amortization 50,777 48,534
Deferred income tax benefit (3,605) (31,341)
Amortization of debt issuance costs, and discount/premium, net 3,403 3,176
Non-cash compensation expense 8,979 24,707
Unrealized changes in fair value of contingent consideration 157 (4,581)
Loss (gain) on sale of operating assets (288) 1,295
Equity in earnings of nonconsolidated affiliates (3,881) (994)
Other, net (50) 315
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (26,374) (48,414)
Increase in prepaid expenses (181,927) (78,273)
Increase in other assets (29,215) (36,744)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 54,787 (22,074)
Increase in deferred revenue 433,301 297,557
Net cash provided by operating activities 264,772 127,768
CASH FLOWS FROM INVESTING ACTIVITIES    
Collections and advances of notes receivable 544 (459)
Distributions from nonconsolidated affiliates 540 340
Investments made in nonconsolidated affiliates (864) (486)
Purchases of property, plant and equipment (28,017) (18,211)
Proceeds from disposal of operating assets, net of cash divested 5,648 2,684
Cash paid for acquisitions, net of cash acquired 0 (7,289)
Purchases of intangible assets (10,002) (107)
Increase in other, net (19) (664)
Net cash used in investing activities (32,170) (24,192)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 29,587 (756)
Payments on long-term debt (36,844) (5,567)
Contributions from noncontrolling interests 130 0
Distributions to and purchases/sales of noncontrolling interests (3,226) (48,579)
Proceeds from exercise of stock options 408 1,003
Proceeds from sale of common stock 0 18,836
Payments for deferred and contingent consideration (10,585) (10,307)
Net cash used in financing activities (20,530) (45,370)
Effect of exchange rate changes on cash and cash equivalents 15,087 36,222
Net increase in cash and cash equivalents 227,159 94,428
Cash and cash equivalents at beginning of period 844,253 892,758
Cash and cash equivalents at end of period $ 1,071,412 $ 987,186